High-mobility-group proteins and cancer—an emerging link Volker WunderlichMichael Böttger Guest Editorial Pages: 133 - 140
DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status Helmut DaubeGerhard SchererFranz Adlkofer Original Paper Pages: 141 - 151
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells Yael ZimraLina WassermanAda Rephaeli Original Paper Pages: 152 - 160
Expression of epidermal growth factor receptor in gestational trophoblastic diseases Prabha BalaramMolykutty JohnKrishnan Nair Original Paper Pages: 161 - 166
Serum levels of interleukins, growth factors and anglogenin in patients with endometrial cancer Vimlarani ChopraTung V. DingEdward V. Hanningan Original Paper Pages: 167 - 172
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial Barbara D. WamilGary B. ThurmanCarl G. Hellerqvist Original Paper Pages: 173 - 179
Surgical therapy for localized prostatic carcinoma Joachim NoldusPeter HammererHartwig Huland Original Paper Pages: 180 - 184
32nd Annual Meeting of the American Society of Clinical Oncology 18–21 May 1996, Philadelphia, Pennsylvania, USA Maurie Markman Meeting Report Pages: 185 - 186
Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats S. KurthD. BulianTh. Riemenschneider Erratum Pages: 187 - 187